TMCI

#3867
Treace Medical Concepts, Inc. Common Stock
2.21 USD
+3.76%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
2.21
2.26
Intervallo Annuale
1.17
7.78
Variazione giornaliera
+3.76%
Variazione Mensile
+49.32%
Variazione di 6 mesi
-64.18%
Variazione Annuale
-66.00%
Chiusura Precedente
2.13
Apertura
2.26
Bid
Ask
Minimo
2.21
High
2.26
Volume
69
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Treace Medical Concepts Inc

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions. In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021.

Notizie